CTOs on the Move

Afferent Pharmaceuticals

www.afferentpharma.com

 
Afferent Pharmaceuticals, Inc. is a leader in the development of novel, selective drugs for the treatment of a range of debilitating neurogenic disorders. These disorders affect millions of patients who suffer from chronic respiratory and urologic sensory pathologies as well as chronic pain, and who have limited, if any, treatment options. These chronic disorders arise when certain nerve fibers become hyper-sensitized as a result of inflammation, distress, infection or tissue injury, and sometimes remain chronically sensitized for months or even years.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Afferent Pharmaceuticals raised $55M on 07/08/2015

Similar Companies

ProStat

ProStat is a Reading, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stelkast

Stelkast is a Canonsburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Boulder Care

Boulder is a digital health platform expanding access to effective treatment for opiate use. We aim to move the behavioral health industry forward by offering dramatically better experiences for patients and their care teams.

Genoa Healthcare LLC

Genoa Healthcare operates on a simple premise: On-site pharmacies are better for patients - and the mental health clinics that serve them.

Journey Colab

We are pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities. We plan to build a portfolio of plant-identical compounds. Our first compound in development is mescaline.